Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian G Feagan

Showing results (211-220 of 464) with videos related to

Pageof 47
Sort By:
BMJ Open|December 9, 2023
Use of external control arms in immune-mediated inflammatory diseases: a systematic reviewAlexa Zayadi, Robert Edge, Claire E Parker, et al.
Alimentary Pharmacology & Therapeutics|November 15, 2024
Meta-Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled TrialsAngelica Rivas, Newaz Shubidito Ahmed, Yuhong Yuan, et al.
Transfusion|May 1, 2007
A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplastyCindy J Wong, Margaret K Vandervoort, Suzanne L Vandervoort, et al.
Inflammatory Bowel Diseases|May 4, 2007
Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitisWalter Reinisch, William J Sandborn, Mohan Bala, et al.
Gastroenterology|March 29, 2016
Efficient Early Drug Development for Ulcerative ColitisReena Khanna, Vipul Jairath, Niels Vande Casteele, et al.
Inflammatory Bowel Diseases|April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysisSudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 26, 2014
The challenge of indication extrapolation for infliximab biosimilarsBrian G Feagan, Denis Choquette, Subrata Ghosh, et al.
Journal of Crohn'S & Colitis|September 21, 2021
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's DiseaseWilliam J Sandborn, James D Lewis, Julian Panes, et al.
The American Journal of Gastroenterology|September 13, 2008
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's diseaseKelvin T Thia, William J Sandborn, James D Lewis, et al.
Journal of Clinical Pathology|February 28, 2024
Identification of immune cell markers associated with ulcerative colitis histological disease activity in colonic biopsiesPavine L C Lefevre, Zhongya Wang, Wendy Teft, et al.
Pageof 47

Showing results (211-220 of 464) with videos related to

Sort By:
Pageof 47
BMJ Open|December 9, 2023
Use of external control arms in immune-mediated inflammatory diseases: a systematic reviewAlexa Zayadi, Robert Edge, Claire E Parker, et al.
Alimentary Pharmacology & Therapeutics|November 15, 2024
Meta-Analysis: Evaluating Placebo Rates Across Outcomes in Eosinophilic Oesophagitis Randomised Controlled TrialsAngelica Rivas, Newaz Shubidito Ahmed, Yuhong Yuan, et al.
Transfusion|May 1, 2007
A cluster-randomized controlled trial of a blood conservation algorithm in patients undergoing total hip joint arthroplastyCindy J Wong, Margaret K Vandervoort, Suzanne L Vandervoort, et al.
Inflammatory Bowel Diseases|May 4, 2007
Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitisWalter Reinisch, William J Sandborn, Mohan Bala, et al.
Gastroenterology|March 29, 2016
Efficient Early Drug Development for Ulcerative ColitisReena Khanna, Vipul Jairath, Niels Vande Casteele, et al.
Inflammatory Bowel Diseases|April 1, 2023
Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysisSudheer K Vuyyuru, Tran M Nguyen, Malcolm Hogan, et al.
Biologicals : Journal of the International Association of Biological Standardization|June 26, 2014
The challenge of indication extrapolation for infliximab biosimilarsBrian G Feagan, Denis Choquette, Subrata Ghosh, et al.
Journal of Crohn'S & Colitis|September 21, 2021
Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's DiseaseWilliam J Sandborn, James D Lewis, Julian Panes, et al.
The American Journal of Gastroenterology|September 13, 2008
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's diseaseKelvin T Thia, William J Sandborn, James D Lewis, et al.
Journal of Clinical Pathology|February 28, 2024
Identification of immune cell markers associated with ulcerative colitis histological disease activity in colonic biopsiesPavine L C Lefevre, Zhongya Wang, Wendy Teft, et al.
Pageof 47